In This Issue

Accreditation Statistics

As of August 1, 2023

Cellular Therapy Entities

  • Accredited: 255
  • Applicants: 26

Cord Blood Banks

  • Accredited: 53
  • Applicants: 9

Congratulations to the following organizations for achieving initial accreditation:

Pennsylvania Hospital, Penn Medicine: Adult autologous hematopoietic progenitor cellular therapy, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation

Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital: Adult autologous hematopoietic progenitor cellular therapy, immune effector cellular therapy administration, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation

A complete list of accredited organizations can be found at www.factglobal.org.

Congratulations to our New Inspectors!

Posted in :: 2018 Volume 4 :: Sunday, November 4th, 2018

The following individuals completed their first active inspection in the time period from August through October 2018. Congratulations and thank you for volunteering your time and expertise to advance cellular therapy! Organizations with personnel who also serve as FACT inspectors typically perform better during on-site inspections than their counterparts without an inspector. If you are interested in serving as an inspector, submit an online application! For a complete list of active FACT inspectors, view the online list of FACT Inspectors.

Anurag Singh, MD, MBBS
Clinical Hematopoietic Cellular Therapy, Clinical Immune Effector Cellular Therapy, Marrow Collection
The University of Kansas Medical Center Blood and Marrow Transplant Program

Guy Klamer, PhD
Cord Blood Banking, Cord Blood Processing
Sydney Cord Blood Bank

Arvin Faundo, MD
Cord Blood Banking, Cord Blood Processing
Cordlife Group Limited

Prashant Nageshwar, MD
Clinical Hematopoietic Cellular Therapy, Clinical Immune Effector Cellular Therapy
Dana-Farber Cancer Institute

Marina Komarovskaya, MD
Processing: Minimal manipulation of HPC, and more than minimal manipulation of any cell type
Yale-New Haven Hospital Stem Cell Transplant Program